Factors influencing real-time RT-PCR results: Application of real-time RT-PCR for the detection of leukemia translocations

Molecular Biology Today

Volumn 3, Issue 3, 2002, Pages 79-84

  Curry, John D ^a   McHale, Cliona ^a   Smith, Martyn T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; RNA;

ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL PROTOCOL; CONTROLLED STUDY; FUSION GENE; HUMAN; LEUKEMIA; PIPETTE; QUALITY CONTROL; RANDOMIZATION; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

EID: 0036755432     PISSN: 14685698     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Amabile M., Giannini B., Testoni N., Montefusco V., Rosti G., Zardini C., Terragna C., Buonamici S., Ottaviani E., Soverini S., Fiacchini M., Bassi S., de Vivo A., Trabacchi E., Saglio G., Pane F., Baccarani M., Tura S., and Martinelli G. 2001. Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia. Haematologica. 86: 252-259.
2. Bustin S.A. 2000. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Enclocrinol. 25: 169-193.
3. Curry J.D., Glaser M.C., and Smith M.T. 2001. Real-Time RT-PCR detection and quantification of E2A- PBX1 fusion genes associated with leukaemia. The British Journal of Haematology. 115: 826-831.
4. Curry J.D., McHale, C.M., and Smith, M.T 2002. Low efficiency of the Moloney murine leukemia virus reverse transcriptase during reverse transcription of rare t(8;21) fusion gene transcripts. Biotechniques. 32: 768-755.
5. Dolken G. 2001. Detection of minimal residual disease. Adv Cancer Res. 82: 133-185
6. Krauter J., Heil G., and Ganser A. 2001. The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease; Malignancy. Hematol. 5: 369-381.
7. Marcucci G., Livak K.J., Bi W., Strout M.P., Bloomfield C.D., and Caligiuri M.A. 1998. Detection of minimal residual disease in patients with AML1/ETO- associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay. Leukemia. 12: 1482-1489.
8. Sugimoto T., Das H., Imoto S., Murayama T., Gomyo H., Chakraborty S., Taniguchi R., Isobe T., Nakagawa T., Nishimura R., and Koizumi T. 2000. Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR. Am J Hematol. 64: 101-106.
9. Tobal K., and Liu Yin J.A. 1998. Molecular monitoring of minimal residual disease in acute myeloblastic leukemia with t(8;21) by RT-PCR. Leuk Lymphoma. 31: 115-120.
10. Tobal K., Newton J., Macheta M., Chang J., Morgenstern G., Evans P.A., Morgan G., Lucas G.S., and Liu Yin J.A. 2000. Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse. Blood. 95: 815-819.
11. van Dongen J.J., Macintyre E.A., Gabert J.A., Delabesse E., Rossi V., Saglio G., Gottardi E., Rambaldi A., Dotti G., Griesinger F., Parreira A., Gameiro P., Diaz M.G., Malec M., Langerak A.W., San Miguel J. F., and Biondi A. 1999. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 13: 1901-1928.
12. Zhang J., and Byrne C.D. 1999. Differential priming of RNA templates during cDNA synthesis markedly affects both accuracy and reproducibility of quantitative competitive reverse-transcriptase PCR. Biochem. J. 337: 231-241.